Filing Details
- Accession Number:
- 0001140361-16-053835
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-18 09:47:51
- Reporting Period:
- 2016-02-16
- Filing Date:
- 2016-02-18
- Accepted Time:
- 2016-02-18 09:47:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
811240 | Biolase Inc | BIOL | Dental Equipment & Supplies (3843) | 870442441 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1021412 | W Jack Schuler | 100 North Field Drive Suite 360 Lake Forest IL 60045 | No | No | Yes | No | |
1661351 | Trust Living Schuler W. Jack | 100 North Field Drive Suite 360 Lake Forest IL 60045 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-02-16 | 3,200 | $0.80 | 6,546,137 | No | 4 | P | Indirect | By Trust |
Common Stock | Acquisiton | 2016-02-17 | 900 | $0.80 | 6,547,037 | No | 4 | P | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Trust |
No | 4 | P | Indirect | By Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 14,800 | Indirect | By spouse |
Footnotes
- These shares are held by the Jack W. Schuler Living Trust (the "Trust"). Mr. Schuler serves as sole trustee to the Trust.
- This price reflects the weighted average purchase price for open-market purchases of shares of Common Stock ("Shares") made by the Reporting Persons on February 16, 2016, within a $1.00 range. The actual prices for these transactions range from $0.798 to $0.80, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.